Nobuhiko Shimizu
Papers
3
Total Citations
12
H-Index
2
About
Nobuhiko Shimizu is a urologic surgeon and researcher whose work centers on improving outcomes in prostate cancer treatment, with a particular focus on the technical and clinical nuances of robot-assisted radical prostatectomy (RARP). His most-cited study, a 2024 retrospective analysis of the learning curve for multiple surgeons using the cumulative sum method, provides critical insights into surgical training and quality assurance, demonstrating how proficiency in RARP can be systematically achieved and monitored. This work, with 6 citations, is foundational for institutions adopting robotic surgery. Dr. Shimizu has also explored novel therapeutic avenues, as seen in his 2025 preliminary study on luteolin, a flavonoid, for prostate cancer patients under active surveillance. This investigation, which has garnered 4 citations, addresses the urgent need for non-toxic chemopreventive agents, offering early evidence of safety and clinical efficacy. Additionally, his 2021 case report on a trocar site hernia leading to intestinal necrosis after RARP highlights his commitment to documenting and mitigating rare but severe surgical complications. Through these contributions, Dr. Shimizu advances both the surgical technique and the pharmacological management of prostate cancer, making his work highly relevant to clinicians and researchers seeking to refine treatment paradigms and improve patient safety.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3